In the US, Gliadel (carmustine systemic) is a member of the drug class alkylating agents and is used to treat Brain Tumor, Glioblastoma Multiforme, Hodgkin's Lymphoma, Malignant Glioma, Multiple Myeloma and Non-Hodgkin's Lymphoma.
- GLIADEL 7.7 MG IMPLANT (Leaflet)
Ingredient matches for Gliadel
Carmustine is reported as an ingredient of Gliadel in the following countries:
- South Africa
- United Kingdom
- United States